Skyrizi 360 mg, Injektionslösung in einer Patrone für ein Dosiergerät

7680689460017 CH-68946 Injektionslösung
Skyrizi 360 mg, Injektionslösung in einer Patrone für ein Dosiergerät
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/03/2026
Patient information leaflet
Français
18/03/2026
Patient information leaflet
Italien
18/03/2026
Summary of Product Characteristics
Allemand
29/05/2025
Summary of Product Characteristics
Français
29/05/2025
Summary of Product Characteristics
Italien
29/05/2025

Detailed composition

Substance Quantity Type Category
risankizumabum
360.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.5 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 2343.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2023

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
68946
Drug name
Skyrizi, Injektionslösung in einer Patrone für ein Dosiergerät
Galenic form
LSILPD
ATC Code
L04AC18
Authorization status
Z
Dispensing category
B
First authorization
14/09/2023
Authorization expiration date
13/09/2028
IT Number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn und Colitis ulcerosa bei Erwachsenen

Package details

Description (FR)
SKYRIZI Sol inj 360 mg/2.4ml Cart, 1pce
Description (DE)
SKYRIZI Inj Lös 360 mg/2.4ml Patr, 1Stk
Market launch
14/09/2023
Narcotic (BTM)
No

Other package sizes (1)

SKYRIZI Sol inj 180 mg/1.2ml Cart, 1pce
1 STU
GTIN: 7680689460024
View
Buy us a coffee Explore the data